GlassScriptPhysician profile
Brett D Roberts
NPI 1104961788
$19,764.02
in general payments reported to CMS, 2019-2025
33 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,865 · 2021: $1,784 · 2022: $366 · 2023: $2,062 · 2024: $700 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,901 · Travel and Lodging: $1,187 · Grant: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,901.31 |
| Travel and Lodging | $1,186.77 |
| Grant | $147.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,107.57 | 2019-2025 | Amplatzer Amulet, Ensite Precision, Nc Trek Neo |
| Medtronic Vascular, INC. | $5,198.32 | 2019-2020 | |
| Biosense Webster, INC. | $3,033.02 | 2019 | |
| Boston Scientific Corporation | $1,493.41 | 2019-2025 | Farapulse, General - Therapies, Rhythmia Mapping System |
| Sanofi-Aventis U.S. LLC | $1,040.98 | 2019-2020 | |
| Medtronic, INC. | $380.39 | 2021-2024 | Pulseselect, Micra, Linq II |
| Pfizer INC. | $341.73 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $330.27 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $213.01 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.13 | 2019-2021 | |
| Amgen INC. | $180.38 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $170.05 | 2019-2023 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $149.47 | 2019-2021 | |
| Edwards Lifesciences Corporation | $142.49 | 2019 | |
| Biotronik INC. | $124.25 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $96.78 | 2019-2024 | |
| Irhythm Technologies, INC. | $61.85 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $59.01 | 2019 | |
| Impulse Dynamics (USA) INC. | $55.60 | 2023 | Optimizer |
| Amarin Pharma, INC. | $55.33 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.32 | 2019-2023 | Lifevest |
| Gilead Sciences, INC. | $47.42 | 2019 | |
| Endologix LLC | $45.43 | 2022 | |
| Braemar Manufacturing, LLC | $36.45 | 2019 | |
| Teleflex LLC | $31.32 | 2019 | |
| Astellas Pharma US INC | $29.29 | 2019 | |
| Itamar Medical INC | $18.62 | 2021 | |
| Esperion Therapeutics, INC. | $15.78 | 2020 | |
| Merck Sharp & Dohme LLC | $15.38 | 2022 | |
| Ge Healthcare | $14.98 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.72 | 2020 | |
| Stryker Corporation | $11.75 | 2019 | |
| Bardy Diagnostics, INC. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.